These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10953733)

  • 1. HIV resistance testing: value for money.
    Omrani AS; Pillay D
    Hosp Med; 2000 May; 61(5):304-5. PubMed ID: 10953733
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant genotyping in HIV-1 therapy.
    Nannini E
    Lancet; 1999 Sep; 354(9184):1121. PubMed ID: 10509523
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction of HIV drug-resistance testing in clinical practice.
    Rodríguez-Rosado R; Briones C; Soriano V
    AIDS; 1999 Jun; 13(9):1007-14. PubMed ID: 10397528
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy.
    Deminie CA; Bechtold CM; Riccardi K; Rose RE; Samanta H; Lin PF; Colonno RJ
    AIDS; 1998 Jan; 12(1):110-2. PubMed ID: 9456262
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapies for HIV infection and genomic drug resistance.
    Katzenstein D
    Lancet; 1997 Oct; 350(9083):970-1. PubMed ID: 9329506
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotyping HIV isolates paves the way to effective treatment regimes.
    Sansom C
    Mol Med Today; 1999 Oct; 5(10):417. PubMed ID: 10498906
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of genotypic resistance testing in selecting therapy for HIV.
    Pèrez-Molina JA; Fernández RA
    JAMA; 2000 Oct; 284(13):1649-50. PubMed ID: 11015790
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.
    Hirsch MS; Brun-Vézinet F; D'Aquila RT; Hammer SM; Johnson VA; Kuritzkes DR; Loveday C; Mellors JW; Clotet B; Conway B; Demeter LM; Vella S; Jacobsen DM; Richman DD
    JAMA; 2000 May; 283(18):2417-26. PubMed ID: 10815085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance testing. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Simon VA;
    IAPAC Mon; 2001 Aug; 7(8):235-7. PubMed ID: 11708276
    [No Abstract]   [Full Text] [Related]  

  • 10. Limitations and uncertainties of resistance testing: a review of "negative" trials. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Sherer R;
    IAPAC Mon; 2001 Aug; 7(8):237-41. PubMed ID: 11708277
    [No Abstract]   [Full Text] [Related]  

  • 11. Limits of resistance testing.
    D'Aquila RT
    Antivir Ther; 2000 Mar; 5(1):71-6. PubMed ID: 10846596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
    Frater AJ; Chaput CC; Weber JN; McClure MO
    AIDS; 2000 Jul; 14(10):1473-5. PubMed ID: 10930175
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of drug resistance-related mutations among HIV-1s in Japan.
    Sugiura W; Matsuda M; Abumi H; Yamada K; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takada N; Kakishita E; Yoshioka A; Kashiwagi S; Shirahata A; Nagai Y
    Jpn J Infect Dis; 1999 Feb; 52(1):21-2. PubMed ID: 10808258
    [No Abstract]   [Full Text] [Related]  

  • 15. Your next nightmare: 28% of new HIV cases may be drug-resistant.
    AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New data brings resistance testing closer to routine clinical use.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(3):6. PubMed ID: 11810872
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV resistance-testing information on web.
    AIDS Treat News; 2000 Feb; (No 337):6. PubMed ID: 11367209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV treatment failure: testing for HIV resistance in clinical practice.
    Perrin L; Telenti A
    Science; 1998 Jun; 280(5371):1871-3. PubMed ID: 9669946
    [No Abstract]   [Full Text] [Related]  

  • 19. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
    de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
    AIDS; 2000 Nov; 14(16):2632-3. PubMed ID: 11101087
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
    Van Laethem K; Witvrouw M; Balzarini J; Schmit JC; Sprecher S; Hermans P; Leal M; Harrer T; Ruiz L; Clotet B; Van Ranst M; Desmyter J; De Clercq E; Vandamme AM
    AIDS; 2000 Mar; 14(4):469-71. PubMed ID: 10770556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.